Targeted Medical Pharma, Inc (TRGM)

[threewheeler]

TRGM TOOK STARTER HERE ON 15-12G FILING https://www.otcmarkets.com/filing/html?id=13014097&guid=z-2MUnYSq3HsSth and SS Market Cap
138,651
10/18/2018
Authorized Shares
100,000,000
10/17/2018
Outstanding Shares
27,730,227
10/17/2018
Restricted
21,337,326
10/17/2018
Unrestricted
6,392,901
10/17/2018
Held at DTC
5,144,557
10/17/2018 if this becomes a R/M play, which I believe it will or why update SS and new filing, it can move very quickly

[TheFinalCD]

Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China

LOS ANGELES--(BUSINESS WIRE)-- Targeted Medical Pharma (OTCQB: TRGM), today announced the completion of an exclusive product licensing agreement with Healthy Focus Limited, a Hong Kong based company that specializes in distributing healthcare products throughout China.

The Agreement grants Healthy Focus an exclusive three-year renewable license for the marketing and sale of Theramine®, Percura™ and Trepadone® in Hong Kong and China. Under the terms of the Agreement, Healthy Focus is responsible for registering all products in China, an initial licensing fee, as well as maintaining annual minimum purchase orders of $500,000 for the first two years, and $1 million in the third year.

“We are excited to partner with Healthy Focus Limited to introduce our products to the Chinese Market,” said Kim Giffoni, Chief Executive Officer at Targeted Medical Pharma. “The execution of this agreement represents a significant expansion of international sales of our proprietary line of health products, and positions us for sustainable growth over the next three years.”

Connect with us on Twitter and Facebook.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that develops medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and the dietary supplement for sinus and immune support, Clearwayz. The products are sold directly to physicians, pharmacies, patients and hospitals in the United States and abroad.

[livingston78]

This biotechnology company will not be able to carry out their operations with only $21,371 in cash for a total current assets of $556,593 including an inventory of $124,857 and an accounts receivable of $181,621. With a current liabilities of $13,221,360 for a current ratio of 0.04 this company is unfortunately insolvent. With a selling, general and administrative of $1,175,219, this company is not serious. Also note that the financial statements are in decline and that several important information is missing. Don’t be tempted by the 100% increase of the price at the last session, it happened with only $9,851 in 53 transactions! Only a manipulation!

[brandao]

Soo they are losing revenues ?

[Hacktheripper]

Thanks for headsup

[skidoo31]

Today

[TJG]

Welcome to the TAUG family TRGM, I believe we can be of great service to you folks.....
http://ih.advfn.com/p.php?pid=nmona&article=62928603&symbol=TRGM

[smallcapguru]

Nestle active in medical food arena with recent acquisitions. Anyone familiar with the acquisitions made and if TRGM similar or somewhat similar to companies Nestle has purchased. TRGM stating they will grow revs 30%+ in 2014 according to first quarter earnings release. Look forward to any thoughts.

[hometownJOE]

With just a couple small sales, the stock crashes? Sad. What's the downside below 50 cents?

[hometownJOE]

Level II shows 500 at the ASK for last trade after a 4,999 block sold at 13:37 (3099 @ $0.66 and 1900 @ $0.751). Hmmmm, I am going to keep an eye on this one. If they're painting the tape, this would make for a good trading stock once the games are over and real volume comes in.

[hometownJOE]

Why is TRGM down so much from last week? Bid support is much weaker too with increase in volume. Someone hitting the bid?

[kranthikumar]

TRGM is having perfect play

[DayTrades]

Good question

[Hacktheripper]

So when are they hitting the M J Market

[TheFinalCD]

Targeted Medical Pharma Reports Initial Results from a Clinical Observation of Medical Foods for Children & Adults with Autism...




Targeted Medical Pharma, Inc. (QB) (USOTC:TRGM)
Intraday Stock Chart

Today : Thursday 19 December 2013
Click Here for more Targeted Medical Pharma, Inc. (QB) Charts.
Addressing the Nutrient Deficiencies Associated with Autism Spectrum Disorders for both Children and Adults

Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced additional preliminary findings from an investigator initiated clinical observation of amino acid based medical foods to address specific nutrient deficiencies in children and young adults with autism spectrum disease (ASD) symptoms.

34 subjects including 29 children and 5 young adults ages seven to twenty-one who were diagnosed with ASD or suffering from related symptoms including explosive behavior, social isolation, and mood disorder were treated with an amino acid based formulation for one to several months. The investigators reported that 33 of the subjects were initial responders and demonstrated significant improvement with regards to decreased disruptive outbursts, improved socialization, improved mood and reduction in drug dose. Patients with explosive outbursts improved an average of 83 percent compared to baseline. The five adults reported improved mood and reduction of anxiety from 50% to 90% and in one case a 100% reduction in symptoms of mania. The investigators caution that the sample for adults is small and that an additional four cases were lost to follow-up.

“The formulations used in the investigation are milligram amounts of precursors to neurotransmitters using a proprietary technology protected by several patents,” said William Shell, M.D., CEO and Chief Science Officer of Targeted Medical Pharma. “Autism affects the way patients metabolize certain nutrients and we believe that our medical food technology is a safe and effective way to increase amino acid and neurotransmitter levels for both children and adults. A key target of the formulation is the glutamine/glutamate access which is known to be disrupted in autistic spectrum disease patients. Measurement of amino acid concentrations in plasma and cerebrospinal fluid indicates a significant alteration of amino acid concentrations demonstrating a specific need for nutritional management of the amino acid concentrations.”

“The current pharmacologic treatments available for this patient population do not address the specific nutrient deficiencies, and are associated with a host of negative side effects,” said David Silver, M.D., President and Chief Operating Officer at Targeted Medical Pharma. “The initial results from this observation show that the symptoms of Autism in children and young adults can potentially be improved by addressing the specific nutritional deficiencies of the disease. The amino acids used in the study are considered generally recognized as safe (GRAS) and no significant side effects were observed.”

A double-blind randomized placebo controlled trial will be initiated shortly.

About Targeted Medical Pharma, Inc.

Targeted Medical Pharma, Inc. is a Los Angeles-based biotechnology company that develops medical foods for the treatment of chronic disease, including pain syndromes, peripheral neuropathy, hypertension, obesity, sleep and cognitive disorders. The company also develops a line of dietary supplements designed to support health and wellness. The company manufactures 10 proprietary medical foods, and recently launched its first dietary supplement, Clearwayz™. The products are sold directly to physicians and pharmacies in the U.S. The company also is developing nutrient-based systems for oral stimulation of progenitor stem cells that differentiate into neurons, red blood cells, pituitary hormones including IGF-I.